Lead Plaintiff Deadline: December 06, 2021
See If You Qualify For Monetary Reward
Please Upload related files below
Fill in below.
Looking for more?
(i) Nano-X’s 510(k) application for the Nanox.ARC was deficient; (ii) accordingly, it was unlikely that the Food and Drug Administration would approve the 510(k) application for the Nanox.ARC in its current form; (iii) as a result, NanoX had overstated the Nanox.ARC’s regulatory and commercial prospects; and (iv) as a result, the Company’s public statements were materially false and misleading at all relevant times.
In order to be included in the lawsuit, you must have incurred a loss on shares of Nano-X purchased or acquired during the class period listed above.
If you suffered a loss in Nano-X during the relevant time frame, you have until December 06, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.